Laguna Blends, Inc. (CSE: LAG) (LB6A.F) (OTC: LAGBF) Announces Data from Cannaceuticals Facial Serum Clinical Trial
Before the opening bell, Laguna Blends, Inc. (OTC: LAGBF) announced some of the highlights of a recent clinical trial completed by Cannaceuticals (“Canna”). The study, which was conducted by BioScreen Testing Services, Inc., highlighted the efficacy of Canna’s cannabidiol (CBD) face serum, with test subjects noticing a 100 percent overall improvement to the appearance of skin within two weeks. These results follow last week’s announcement of Laguna’s entry into a non-binding letter of intent with Cannaceuticals of California, USA whereby the two companies will look to enter into a definitive manufacturing and exclusive license agreement for the purpose of pursuing…